Influence of Perioperative Factors on Patency After Endovascular and Hybrid Treatments of TASC II D Aortoiliac Occlusive Lesions

• Published in: Annals of vascular surgery Vol. 99; pp. 252 - 261
• Main Authors: Kriens, Myriam, Jayet, Jérémie, Gallien, Yves, Mercier, Lucie, Javerliat, Isabelle, Coggia, Marc, Coscas, Raphaël
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-02-2024
• Subjects: Arterial Occlusive Diseases - diagnostic imaging; Arterial Occlusive Diseases - surgery; Atherosclerosis; Consensus; Endovascular Procedures; Humans; Iliac Artery - diagnostic imaging; Iliac Artery - surgery; Retrospective Studies; Risk Factors; Stents; Treatment Outcome; Vascular Patency
• ISSN: 0890-5096; 1615-5947
• DOI: 10.1016/j.avsg.2023.08.018

Treatment of Trans-Atlantic Inter-Society Consensus (TASC) II D aortoiliac occlusive disease (AIOD D) remains a controversial topic. Although current recommendations support conventional surgical treatment, several recent studies have reported promising results with endovascular and hybrid strategies. The purpose of this work was to describe the outcomes of endovascular and hybrid management of AIOD D and to investigate the influence of perioperative factors on patency.
This was a retrospective single-center study covering the period from 2016 to 2021. The primary end point was primary patency at 12 months. Secondary endpoints included technical success rate, 30-day mortality, early major complication rate, primary assisted and secondary patency at 12 months, and primary patency at 24 months. After descriptive statistical analysis, a survival analysis was conducted using the Kaplan-Meier method. Eighteen perioperative factors potentially associated with primary patency were studied by univariate and multivariate analysis adjusted by a Cox regression model.
In all, 82 patients (112 limbs) had undergone an attempt at endovascular (n = 55, 67%) or hybrid (n = 27, 33%) treatment for AIOD D over the study period. The technical success rate was 99%. The 30-day mortality rate was 3%. The early major complication rate was 11%. The primary patency rates at 12 and 24 months were 87.9% [80.3; 96.3] and 77% [66.3; 89.3], respectively. The primary assisted and secondary patency rates at 12 months were 92.6% [86.3; 99.2] and 96% [91.4; 100]. Among the perioperative factors studied, the heavily calcified nature of the target lesions was the only variable significantly associated with primary patency loss in the multivariate analysis (P = 0.021).
Although the results of endovascular and hybrid treatment of AOID D are acceptable, future studies should focus on improving patency rates in heavily calcified lesions. Specific tools of endovascular preparation (intravascular lithotripsy, atherectomy) may represent interesting ways of research.